Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples